Protara Therapeutics, Inc. (TARA)
3.88
+0.03
(+0.78%)
USD |
NASDAQ |
Aug 24, 16:00
3.88
0.00 (0.00%)
After-Hours: 20:00
Protara Therapeutics Shareholders Equity (Quarterly) : 161.31M for June 30, 2026
Shareholders Equity (Quarterly) Chart
Sep '18
Jan '19
May '19
285.00
270.00
255.00
240.00
Historical Shareholders Equity (Quarterly) Data
| Date | Value |
|---|---|
| June 30, 2026 | 161.31M |
| March 31, 2026 | 181.21M |
| December 31, 2025 | 196.41M |
| September 30, 2025 | 132.29M |
| June 30, 2025 | 144.42M |
| March 31, 2025 | 158.48M |
| December 31, 2024 | 167.13M |
| September 30, 2024 | 81.79M |
| June 30, 2024 | 92.05M |
| March 31, 2024 | 58.41M |
| December 31, 2023 | 68.32M |
| September 30, 2023 | 76.96M |
| June 30, 2023 | 85.22M |
| March 31, 2023 | 94.77M |
| December 31, 2022 | 102.08M |
| September 30, 2022 | 139.18M |
| June 30, 2022 | 145.46M |
| March 31, 2022 | 152.24M |
| December 31, 2021 | 161.91M |
| September 30, 2021 | 170.41M |
| June 30, 2021 | 178.40M |
| March 31, 2021 | 188.13M |
| December 31, 2020 | 199.24M |
| September 30, 2020 | 194.63M |
| June 30, 2020 | 59.43M |
| Date | Value |
|---|---|
| March 31, 2020 | 64.74M |
| December 31, 2019 | -2.128M |
| September 30, 2019 | 8.035M |
| June 30, 2019 | 9.477M |
| March 31, 2019 | 14.69M |
| December 31, 2018 | 20.44M |
| September 30, 2018 | 24.87M |
| June 30, 2018 | 25.62M |
| March 31, 2018 | 29.49M |
| December 31, 2017 | 34.74M |
| September 30, 2017 | 39.47M |
| June 30, 2017 | 29.49M |
| March 31, 2017 | 33.00M |
| December 31, 2016 | 38.44M |
| September 30, 2016 | 44.52M |
| June 30, 2016 | 50.92M |
| March 31, 2016 | 57.75M |
| December 31, 2015 | 63.40M |
| September 30, 2015 | 69.03M |
| June 30, 2015 | 73.76M |
| March 31, 2015 | 78.29M |
| December 31, 2014 | 82.46M |
| September 30, 2014 | 9.618M |
| June 30, 2014 | 14.61M |
| March 31, 2014 | -6.923M |
Shareholders' Equity Definition
Represents the value of Shareholders' Equity as of the close of the report date, belonging to both Preferred and Common Equity Shareholders.
Shareholders Equity (Quarterly) Range, Past 5 Years
--
Minimum
--
Maximum
--
Average
--
Median
Shareholders Equity (Quarterly) Benchmarks
| NovelStem International Corp. | -2.032M |
| Brainstorm Cell Therapeutics, Inc. | -11.60M |
| Summit Therapeutics, Inc. | 629.98M |
| Kezar Life Sciences, Inc. | 65.24M |
| Clene, Inc. | -24.78M |
Shareholders Equity (Quarterly) Related Metrics
| Total Assets (Quarterly) | 176.09M |
| Total Liabilities (Quarterly) | 14.78M |
| Debt to Equity Ratio | 0.017 |
| Current Ratio | 10.97 |
| Net Debt Paydown Yield | 0.13% |